| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 1,076 | 49 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 1,076 | 49 | | | Operating Expenses | | Research Development | 10,535 | 4,931 | | Selling General and Administrative | 5,136 | 5,595 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (14,596) | (10,477) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 225 | (3,011) | | Earnings Before Interest And Taxes | (14,371) | (13,488) | | Interest Expense |
-
| 788 | | Income Before Tax | (14,371) | (14,276) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (14,371) | (14,276) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (14,371) | (14,276) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($14,371) | ($14,276) |
|
0.20% Nasdaq 
0.07 (6.86%) 
Income Statement
